Latest filing published 17 Aug 2023 for Beauty Health Co, €92k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Andrew Roy Stanleick: trading record in brief
Andrew Roy Stanleick (chief executive) discloses dealings in SkinHealth Systems Inc. to SEC (Form 4). Over a trading history stretching from 7 February 2022 to 17 August 2023, the count stands at 4 filings.
Purchases make up the whole of the open-market record (1 purchase, €92k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants. In 2023 alone, the filings show 1 purchase and no sales.
The latest filing, published on 17 August 2023, reports an open-market purchase of €92k in SkinHealth Systems Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Roy Stanleick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,485 shares@ US$6.0549100.0% of flowClass A Common StockSEC:0001628280-23-029852:0Canonical exit: 15 Nov 2023 (T+90)
- 294,579 sharesClass A Common StockSEC:0001628280-23-011061:0
- 58,536 sharesClass A Common StockSEC:0001818093-23-000011:0
- 333,333 sharesClass A Common StockSEC:0001818093-22-000035:0
4 of 4 declarations
